Back
AstraZeneca PLC 10K Form
Sell
44
AZN
AstraZeneca PLC
Last Price:
64.25
Seasonality Move:
0.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AZN News And Ratings
See the #1 stock for the next 7 days that we like better than AZN
AZN Financial Statistics
Sales & Book Value
| Annual Sales: | $45.81B |
|---|---|
| Cash Flow: | $2.03B |
| Price / Cash Flow: | 29.72 |
| Annual Sales: | $13.13 |
| Price / Book: | 4.89 |
Profitability
| EPS (TTM): | 2.08500 |
|---|---|
| Net Income (TTM): | $6.5B |
| Gross Margin: | $37.54B |
| Return on Equity: | 16.72% |
| Return on Assets: | 6.38% |
AstraZeneca PLC Earnings Forecast
Key AstraZeneca PLC Financial Ratios
- The Gross Profit Margin over the past 26 years for AZN is 81.95%.
- The Selling, General & Administrative Expenses for AZN have been equal to 39.78% of Gross Profit Margin.
- The Research & Development expenses have been 23.87% of Revenue.
- The Interest Expense is 26.68% of Operating Income.
- The Net Earning history of AZN is 13.00% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 20 years.
AstraZeneca PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AZN |
| CUSIP: | 046353 |
| Website: | astrazeneca.com |
Debt
| Debt-to-Equity Ratio: | 0.74 |
|---|---|
| Current Ratio: | 0.93 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 33.73 |
|---|---|
| Forward P/E Ratio: | 13.45 |
AZN Technical Analysis vs Fundamental Analysis
Sell
44
AstraZeneca PLC (AZN)
is a Sell
Is AstraZeneca PLC a Buy or a Sell?
-
AstraZeneca PLC stock is rated a Sell
The current AstraZeneca PLC [AZN] share price is $64.26. The Score for AZN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.